Biotech Values

[drbio45]

Another investor, Ed Pooner of San Rafael, Calif., focused more on the FDA's action requiring more data. He called that action "alarming," saying it's the first time since the 1950s that the agency declined to approve a drug over the vote of an advisory committee of physicians recommending the drug's release. The committee voted 17-0 in favor of the drug's safety and 13-4 in favor of its efficiency, according to Dendreon.

where did that nonsense about the 1950'come from and how can the reporter print it and not mention that it was a quote but the info in the quote was nonsense.